Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > More competitors for THRM - They need to act soon
View:
Post by snow13 on May 20, 2021 10:31am

More competitors for THRM - They need to act soon

New Delhi: 

CoviSelf - India's first self-use Rapid Antigen Test (RAT) kit - will take two minutes to carry out the test and results will be available in 15 minutes, the Pune-based firm that produced the kit said.

The test kit was approved by the Indian Council of Medical Research (ICMR) - the nodal body in the fight against the virus - on Wednesday.

"It takes two minutes to conduct test and 15 minutes to get result. It will be available by end of next week in more than seven lakh pharmacies and our online pharmacy partners across India. Our target is to reach 90 per cent pin code in India," Sujeet Jain, Director of Mylab Discovery Solutions - the firm that produced the kit - was quoted by news agency ANI.

"This test is for self-use. If you test positive via this there is no need for RT-PCR test, as per ICMR. Any adult can use this kit by reading our manual," he added.

Only symptomatic individuals and immediate contacts of people who have tested positive in laboratory-conducted tests should use this kit, the ICMR has said. "Indiscriminate testing is not advised," the top medical body said while issuing detailed guidelines on the kit's use.

 

"All symptomatic individuals who test negative by RAT should get themselves immediately tested by RT-PCR," the ICMR added.

CoviSelf test results will have to be uploaded to a mobile app that can be downloaded from Google's Play Store or the Apple Store, the ICMR said.

Comment by forrest6748 on May 20, 2021 10:48am
IT IS A NASAL TEST Here is all you need to know about the home-based rapid antigen testing kit for Covid-19: 1) The home-based rapid antigen testing kit manufactured by Mylab Discovery Solutions Ltd, Pune, has been validated and approved by the ICMR. 2) Only a nasal swab will be required for this rapid antigen testing. 3) The name of the kit is CoviSelfTM(PathoCatch) COVID-19 OTC Antigen ...more  
Comment by abcd2020 on May 20, 2021 10:51am
test is test, doesnt matter how its done... $15 stilll COFFFFFFEEEE
Comment by Smokey1958 on May 20, 2021 11:29am
I'm not sure it's competition but it certainly is notable that there are others filling specific niches. What they have in their favour is scale up capacity. The price of $4.15 CDN for a test may very well make it impossible for those that might need it most. Two other pieces of note ....it can only be used for symptomatic individuals. If you test positive you follow up appropriately ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities